{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:36:01Z","timestamp":1790019361802,"version":"4.0.1"},"reference-count":45,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"2","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>We assessed the availability, price, and affordability of commonly used chemotherapy medications in Cameroon, Ethiopia, Kenya, and Malawi. We also examined the characteristics that could predict chemotherapy medication quality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Samples of seven commonly used chemotherapy medications were collected: cisplatin, cyclophosphamide, doxorubicin, ifosfamide, leucovorin, methotrexate, and oxaliplatin. Stockouts and medicine prices were recorded at public national hospitals and community pharmacies. Using the National Comprehensive Cancer Network's harmonized guidelines for sub-Saharan Africa, we estimated the costs of medications to treat early-stage breast cancer, colorectal cancer (CRC), and head and neck cancer. Every sample was tested for quality using high-performance liquid chromatography against USP standards. We ran logistic regressions to assess medicine characteristics that could predict substandard and falsified chemotherapy medications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Stockouts of chemotherapy medications in public hospitals were observed in three of four countries. Other than in Malawi where medications are free when available in the public sector, chemotherapy medications were unaffordable, costing government worker salary equivalents of 47-242 days, 233-869 days, and 22-196 days to treat early-stage breast cancer, CRC, and head and neck cancer, respectively. On average across the population, $36 US dollars (USD) (95% CI, $50 USD to $134 USD, 9%-25% of medication cost) was spent on poor-quality medicines for treatment of breast cancer, $32 USD (95% CI, $6 USD to $214 USD, 0.5%-17%) for CRC, and $15 USD (95% CI, $4 USD to $49 USD, 2%-21%) for head and neck cancer. Price of the medication, public\/private source, and medicine registration status were poor predictors of medicine quality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>We found that medicines for cancer treatment are unaffordable without government subsidies. Moreover, poor-quality chemotherapy medicines are hard to detect without chemical testing. Government policies and supply chain practice changes are needed to improve the availability, affordability, and quality of chemotherapy medications in sub-Saharan Africa.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/go-25-00118","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T20:58:11Z","timestamp":1770238691000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":2,"title":["Chemotherapy Medications in Sub-Saharan Africa: Availability, Pricing, Affordability, and Predictors of Quality"],"prefix":"10.1200","volume":"12","author":[{"given":"Colleen R.","family":"Higgins","sequence":"first","affiliation":[{"name":"Division of Practice Advancement and Clinical Education, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian J.","family":"Wilfinger","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1886-9444","authenticated-orcid":true,"given":"Jack","family":"Doohan","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1967-4713","authenticated-orcid":true,"given":"Ekezie","family":"Okorigwe","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2505-899X","authenticated-orcid":true,"given":"Ayenew","family":"Ashenef","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry and Pharmacognosy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia"},{"name":"College of Health Sciences, Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6065-0695","authenticated-orcid":true,"given":"Atalay Mulu","family":"Fentie","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, Addis Ababa University, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Chikowe","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Kamuzu University of Health Sciences (KUHES), Blantyre, Malawi"},{"name":"Department of Pharmacy, College of Pharmacy, Korea University, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3177-9497","authenticated-orcid":true,"given":"Hanna Stanbuli","family":"Kumwenda","sequence":"additional","affiliation":[{"name":"University of North Carolina Project, Lilongwe, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Ndom","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Biomedical Sciences, University of Yaounde, Yaound\u00e9, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0571-0074","authenticated-orcid":true,"given":"Yauba","family":"Saidu","sequence":"additional","affiliation":[{"name":"Clinton Health Access Initiative Inc, Yaound\u00e9, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5464-533X","authenticated-orcid":true,"given":"Jesse","family":"Opakas","sequence":"additional","affiliation":[{"name":"Hemato-Oncology Directorate, Moi Teaching and Referral Hospital, Eldoret, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4259-695X","authenticated-orcid":true,"given":"Sonak","family":"Pastakia","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Purdue University, West Lafayette, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phelix Makoto","family":"Were","sequence":"additional","affiliation":[{"name":"Academic Model Providing Access to Healthcare (AMPATH), Moi Teaching and Referral Hospital, Eldoret, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2387-6676","authenticated-orcid":true,"given":"Benyam","family":"Muluneh","sequence":"additional","affiliation":[{"name":"Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3968-8044","authenticated-orcid":true,"given":"Marya","family":"Lieberman","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7608-9038","authenticated-orcid":true,"given":"Sachiko","family":"Ozawa","sequence":"additional","affiliation":[{"name":"Division of Practice Advancement and Clinical Education, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC"},{"name":"Department of Maternal and Child Health, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_7_2_2","volume-title":"Cancer Today Globocan 2022, Global Cancer Observatory, Sub-Saharan Africa Statistics at a Glance","author":"World Health Organization","year":"2022","unstructured":"World Health Organization: Cancer Today Globocan 2022, Global Cancer Observatory, Sub-Saharan Africa Statistics at a Glance. Geneva, Switzerland, World Health Organization, International Agency for Research on Cancer, 2022"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00270-4"},{"key":"e_1_3_7_4_2","volume-title":"The Global Health Observatory, SDG Target 3.4 Reduce by One Third Premature Mortality from Non-Communicable Diseases Through Prevention and Treatment and Promote Mental Health and Well-Being","author":"World Health Organization","year":"2025","unstructured":"World Health Organization: The Global Health Observatory, SDG Target 3.4 Reduce by One Third Premature Mortality from Non-Communicable Diseases Through Prevention and Treatment and Promote Mental Health and Well-Being. Geneva, Switzerland, World Health Organization, 2025"},{"key":"e_1_3_7_5_2","volume-title":"Access to Medicines: Making Market Forces Serve the Poor","author":"World Health Organization","year":"2017","unstructured":"World Health Organization: Access to Medicines: Making Market Forces Serve the Poor. Geneva, Switzerland, World Health Organization, 2017"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-023-01962-y"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.1662"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/20523211.2024.2375267"},{"key":"e_1_3_7_9_2","volume-title":"Substandard and Falsified Medical Products","author":"World Health Organization","year":"2024","unstructured":"World Health Organization: Substandard and Falsified Medical Products. Geneva, Switzerland, World Health Organization, 2024"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.15236.1"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.21-1123"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyac143"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00072-4"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102005"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-13586-2"},{"key":"e_1_3_7_16_2","volume-title":"World Bank Country and Lending Groups","author":"The World Bank","year":"2024","unstructured":"The World Bank: World Bank Country and Lending Groups, 2024"},{"key":"e_1_3_7_17_2","volume-title":"Exchange Rates API","author":"Convert M","year":"2023","unstructured":"Convert M: Exchange Rates API, 2023"},{"key":"e_1_3_7_18_2","volume-title":"NCCN Harmonized Guidelines","author":"National Comprehensive Cancer Network","year":"2024","unstructured":"National Comprehensive Cancer Network: NCCN Harmonized Guidelines. Plymouth Meeting, PA, NCCN, 2024"},{"key":"e_1_3_7_19_2","volume-title":"Salary Increases Approved for Ethiopian Government Employees: Key Details Inside, Addis Insight","author":"Addis Insight","year":"2024","unstructured":"Addis Insight: Salary Increases Approved for Ethiopian Government Employees: Key Details Inside, Addis Insight. Addis Ababa, Ethiopia, Addis Insight, 2024"},{"key":"e_1_3_7_20_2","volume-title":"2024 Malawi Civil Service Salary Structure: Updated Grades and Pay Scales","author":"Ntchito","year":"2024","unstructured":"Ntchito: 2024 Malawi Civil Service Salary Structure: Updated Grades and Pay Scales. Malawi, Ntchito.com, 2024"},{"key":"e_1_3_7_21_2","volume-title":"Job Groups in Kenya, Salaries, and Allowances According to SRC 2024","author":"Ayub S","year":"2024","unstructured":"Ayub S: Job Groups in Kenya, Salaries, and Allowances According to SRC 2024. Tuko, Kenya, TUKO.co.ke, 2024"},{"key":"e_1_3_7_22_2","volume-title":"Fixant Le Salire Minimum Interprofessionnel Garanti Des Agents De L'Etat Relevant Du Code Du Travail, Decret No. 2024\/0168\/PM du 23 Fev 2024","author":"Republic of Cameroon Prime Minister\u2019s Office","year":"2024","unstructured":"Republic of Cameroon Prime Minister\u2019s Office. In: PMs Office (ed): Fixant Le Salire Minimum Interprofessionnel Garanti Des Agents De L'Etat Relevant Du Code Du Travail, Decret No. 2024\/0168\/PM du 23 Fev 2024. Cameroon, Republic of Cameroon Prime Minister\u2019s Office, 2024"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(25)00138-X"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/9781118625590"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1927.10502953"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.628744"},{"key":"e_1_3_7_27_2","doi-asserted-by":"publisher","DOI":"10.2147\/RMHP.S395456"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.1080\/08880018.2022.2139028"},{"key":"e_1_3_7_29_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1379250"},{"key":"e_1_3_7_30_2","first-page":"1601","article-title":"Assessment of barriers to optimal cancer control in adult cancer treatment centres in Cameroon","volume":"17","author":"Mapoko BSE","year":"2023","unstructured":"Mapoko BSE, Frambo A, Saidu Y, et al: Assessment of barriers to optimal cancer control in adult cancer treatment centres in Cameroon. Ecancermedicalscience 17:1601, 2023","journal-title":"Ecancermedicalscience"},{"key":"e_1_3_7_31_2","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S413546"},{"key":"e_1_3_7_32_2","article-title":"Paper analytic device to detect the presence of four chemotherapy drugs","author":"Smith M","unstructured":"Smith M, Ashenef A, Lieberman M: Paper analytic device to detect the presence of four chemotherapy drugs. JCO Glob Oncol 10.1200\/JGO.18.00198","journal-title":"JCO Glob Oncol"},{"key":"e_1_3_7_33_2","article-title":"Substandard cisplatin found while screening the quality of anticancer drugs from Addis Ababa, Ethiopia","author":"Eberle MS","unstructured":"Eberle MS, Ashenef A, Gerba H, et al: Substandard cisplatin found while screening the quality of anticancer drugs from Addis Ababa, Ethiopia. JCO Glob Oncol 10.1200\/JGO.19.00365","journal-title":"JCO Glob Oncol"},{"key":"e_1_3_7_34_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmedt.2024.1436614"},{"key":"e_1_3_7_35_2","doi-asserted-by":"publisher","DOI":"10.1177\/2399202620980303"},{"key":"e_1_3_7_36_2","volume-title":"Strengthening Regulatory Systems to Improve Medical Product Quality in Low- and Middle-Income Countries","author":"Kaddu GDAE","year":"2018","unstructured":"Kaddu GDAE, Clark A, Nkansah P: Strengthening Regulatory Systems to Improve Medical Product Quality in Low- and Middle-Income Countries. Rockville, Maryland, Promoting the Quality of Medicines (PQM) Program, US Pharmacopeial Convention, 2018"},{"key":"e_1_3_7_37_2","first-page":"117","article-title":"The three-level approach: A framework for ensuring medicines quality in limited-resource countries","volume":"3","author":"Pribluda V","year":"2014","unstructured":"Pribluda V, Barojas A, Coignez V, et al: The three-level approach: A framework for ensuring medicines quality in limited-resource countries. Pharmaceut Regul Aff 3:117, 2014","journal-title":"Pharmaceut Regul Aff"},{"key":"e_1_3_7_38_2","volume-title":"Risk-Based Post-Marketing Surveillance of Medicines: Implementation Resources for Low- and Middle-Income Countries","author":"US Pharmacopeial Convention","year":"2021","unstructured":"US Pharmacopeial Convention: Risk-Based Post-Marketing Surveillance of Medicines: Implementation Resources for Low- and Middle-Income Countries. Rockville, Maryland, 2021"},{"key":"e_1_3_7_39_2","first-page":"112, XL","volume-title":"Technical Report: Pricing of Cancer Medicines and Its Impacts: A Comprehensive Technical Report for the World Health Assembly Resolution 70.12: Operative Paragraph 2.9 on Pricing Approaches and Their Impacts on Availability and Affordability of Medicines for the Prevention and Treatment of Cancer","author":"World Health Organization","year":"2018","unstructured":"World Health Organization: Technical Report: Pricing of Cancer Medicines and Its Impacts: A Comprehensive Technical Report for the World Health Assembly Resolution 70.12: Operative Paragraph 2.9 on Pricing Approaches and Their Impacts on Availability and Affordability of Medicines for the Prevention and Treatment of Cancer. Geneva, World Health Organization, 2018. p 112, XL"},{"key":"e_1_3_7_40_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-015-0043-8"},{"key":"e_1_3_7_41_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-023-09706-y"},{"key":"e_1_3_7_42_2","first-page":"52","article-title":"Availability and affordability of anticancer medicines at the Ocean Road Cancer Institute in Dar es Salaam, Tanzania","volume":"8","author":"Yohana E","year":"2011","unstructured":"Yohana E, Kamuhabwa A, Mujinja P: Availability and affordability of anticancer medicines at the Ocean Road Cancer Institute in Dar es Salaam, Tanzania. East Afr J Public Health 8:52-57, 2011","journal-title":"East Afr J Public Health"},{"key":"e_1_3_7_43_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0279817"},{"key":"e_1_3_7_44_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_3_7_45_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21708"},{"key":"e_1_3_7_46_2","unstructured":"Africa CDC: Africa CDC Diagnostic Advisory Committee (DAC) for In-Vitro Diagnostics (IVDs). Addis Ababa Ethiopia Africa Centres for Disease Control and Prevention 2025"}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO-25-00118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T18:33:51Z","timestamp":1772562831000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO-25-00118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1200\/GO-25-00118"],"URL":"https:\/\/doi.org\/10.1200\/go-25-00118","relation":{},"ISSN":["2687-8941"],"issn-type":[{"value":"2687-8941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"2025-02-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2500118"}}